MichaelConstantineMD

Oncology • Milford, MA

Physician

Join to view full profile

Dr. Constantine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Constantine's full profile

Already have an account?

Office
14 Prospect St
Hill Health Building
Milford, MA 01757
Phone+1 508-478-2061

Fax+1 508-478-7768

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1988 - 1992
Tufts University School of MedicineClass of 1988

Certifications & Licensure

MA State Medical License 1992 - 2025
NJ State Medical License 1990 - 1993

Clinical Trials

Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma Start of enrollment: 2009 Jun 01
Completed
Phase 1, Phase 2
Study of Vitamin D in Untreated Metastatic Colorectal Cancer Start of enrollment: 2012 Apr 13
Completed
Phase 2
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01
Active, not recruiting
Phase 2
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation Start of enrollment: 2018 Jan 01
Completed
Not Applicable
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma Start of enrollment: 2021 Apr 27
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Corre...
Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau Dang, Denise A Yardley
Journal of Clinical Oncology. 2024-11-01
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial.
Anna Weiss, Tianyu Li, Neelam V Desai, Nadine M Tung, Philip D Poorvu
Journal of the American College of Surgeons. 2023-08-01
19 citations
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.
Adrienne G Waks, Neelam V Desai, Tianyu Li, Philip D Poorvu, Ann H Partridge
NPJ Breast Cancer. 2022-05-10

Press Mentions

Massage Therapist West Palm Beach, FlJanuary 21st, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member